Kabifungin (Caspofungin)

Benefits:

Endorsed by IDSA for empirical antifungal therapy of invasive candidiasis in neutropenic patients

Proven efficacy for invasive aspergillosis in patients refractory to or intolerant of other antifungal therapies

Offers wide range of indications for Candida & Aspergillus treatment and empirical

Characteristics:

Kabifungin-50 contains 50 mg Caspofungin

Kabifungin-70 contains 70 mg Caspofungin

Indications

Invasive fungal infections

Presentation

Available in 50 & 70 mg vial